Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Association of Clinical Epidemiologic Exposures and Overall Survival with Genome-Wide DNA Methylation Profiles in Acute Myeloid Leukemia: Analysis of the Mayo Clinic AML Epidemiology Cohort

César J. Torres-Gutierrez, BS, Michael G. Heckman, Ryan A. Hlady, Rhett P. Ketterling, Lisa Z. Sproat, Kathryn E. Pearce, Elizabeth R. Lesser, Nancy N. Diehl, Laura E. Finn, Liuyan Jennifer Jiang, Keith D. Robertson, James R. Cerhan, MD PhD, James M. Foran, MD

Blood (2018) 132 (Supplement 1): 3987.

https://doi.org/10.1182/blood-2018-99-119386

Published: 2018

Journal Articles

Utilizing Y Chromosome FISH to Determine the Origin of Post-Transplant Lymphoproliferative Disease in Solid Organ Transplant Recipients

James B. Ford, DO, Sanmann N Jennifer, PhD, Kelly Erickson, Wendy J Grant, MD, Pamela A Althof, MS, Alan Langnas, Valerie Shostrom, Martin Bast, Timothy C. Greiner, MS, MD, Peter F. Coccia, MD

Blood (2018) 132 (Supplement 1): 5297.

https://doi.org/10.1182/blood-2018-99-119488

Published: 2018

Journal Articles

Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?

Abhishek Mangaonkar, MD, Mrinal M. Patnaik, MDMBBS, Kathleen Kaiser-Rogers, Kathleen Waldron Rao, PhD, Kevin Halling, MD PhD, Gavin Oliver, Michelle A. Elliott, MD, Patricia Greipp, DO, Daniel L. Van Dyke, PhD

Blood (2017) 130 (Supplement 1): 1702.

https://doi.org/10.1182/blood.V130.Suppl_1.1702.1702

Published: 2017

Journal Articles

Indirect Presentation of Y-Chromosome Antigen Dby Is Regulated By Hsc70 and Mediated through CD63 Positive Exosomes

Sascha Kretschmann, Heiko Bruns, PhD, Ursula Schlötzer-Schrehardt, PhD, Andreas Mackensen, MD, Marieke Griffioen, PhD, Anita Kremer

Blood (2016) 128 (22): 3712.

https://doi.org/10.1182/blood.V128.22.3712.3712

Published: 2016

Journal Articles

Isolate Loss of Y Chromosome Decreases the Risk of Leukemic Transformation in the Myelodysplastic Syndromes. a Study By the Spanish Group of Myelodysplastic Syndromes

Blood (2016) 128 (22): 4331.

https://doi.org/10.1182/blood.V128.22.4331.4331

Published: 2016

Journal Articles

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Katja Sockel, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Uwe Platzbecker

Blood (2016) 128 (22): 5531.

https://doi.org/10.1182/blood.V128.22.5531.5531

Published: 2016

Journal Articles

The Targeted Disruption of Kdm6a/Utx in Mice Has Gender-Dependent Effects on Primitive Hematopoietic Cell Populations and Myeloid Progenitors

Ling Tian, PhD, Lukas D. Wartman, MD

Blood (2015) 126 (23): 1158.

https://doi.org/10.1182/blood.V126.23.1158.1158

Published: 2015

Journal Articles

Cytogenetic Features and Prognosis of 943 South American Patients with De Novo Myelodysplastic Syndromes: A Multicenter Study

Carolina Belli, PhD, Ronald Feitosa Pinheiro, MD PhD, Silvia M. M. Magalhaes, MD, Jacqueline Gonzalez, MD, Marcelo Iastrebner, MD, Maria Virginia Prates, MD, Silvia Benasayag, Yesica Bestach, MSc, Juliana Cordeiro, Marcela Cavalcante de Andrade Silva, Roberta da Silva Tanizawa, Raquel M Bengió, MD, Cecilia Lang, Elsa Nucifora, MD, Irene B Larripa, PhD, Elvira RP Velloso, MD PhD

Blood (2014) 124 (21): 5618.

https://doi.org/10.1182/blood.V124.21.5618.5618

Published: 2014

Journal Articles

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Mohamed Abdelfatah, Adel Al-Alwan, Zeyad Kanaan, Mark R Litzow, MD, Alexandra Wolanskyj, Kebede Begna, William Hogan, MD, Daniel L. Van Dyke, Ph.D., Aref Al-Kali, MD

Blood (2012) 120 (21): 4804.

https://doi.org/10.1182/blood.V120.21.4804.4804

Published: 2012

Journal Articles

Vaccinating Female Donors with Y Chromosome-Encoded Disparities in the Pre-Clinical Canine Model of Allogeneic Hematopoietic Cell Transplantation

Steven Lawrence Rosinski, M.D., Ph.D., Scott Stoll Graves, PH.D., Rainer Storb, MD, Brad Stone, PhD

Blood (2012) 120 (21): 4123.

https://doi.org/10.1182/blood.V120.21.4123.4123

Published: 2012

Journal Articles

Proof of Y-Loss As Clonal Abnormality in MDS by Comparative Analysis of CD34+ and CD3+ Peripheral Blood Cells,

Christina Ganster, Friederike Braulke, Katayoon Shirneshan, Dietrich Kämpfe, Uwe Platzbecker, MD, Ulrike Söling, Carsten P Bramlage, Tobias J Legler, Detlef Haase, Julie Schanz

Blood (2011) 118 (21): 3800.

https://doi.org/10.1182/blood.V118.21.3800.3800

Published: 2011

Journal Articles

Impact of Additional Cytogenetic Alterations At Diagnosis on Prognosis of CML: Long-Term Observation From 1151 Patients of the Randomized CML Study IV

Blood (2011) 118 (21): 782.

https://doi.org/10.1182/blood.V118.21.782.782

Published: 2011

Journal Articles

Loss of the Y Chromosome in MDS - Age-Related Phenomenon or Clonal Abnormality?

Blood (2010) 116 (21): 4008.

https://doi.org/10.1182/blood.V116.21.4008.4008

Published: 2010

Journal Articles

In Vitro Expanded MSCs From Patients with Myeloprliferative Neoplasms at Late Passages Show Recurrent Cytogenetic Abnormalities

Valentina Achille, Francesca Novara, Melissa Mantelli, Maria Antonietta Avanzini, Vittorio Rosti, MD, Rita Maccario, Maria ester Bernardo, Franco Locatelli, Marco Zecca, Orsetta Zuffardi, Giovanni Barosi, MD

Blood (2010) 116 (21): 4101.

https://doi.org/10.1182/blood.V116.21.4101.4101

Published: 2010

Journal Articles

Impact of Variant t(9;22) and Additional Cytogenetic Aberrations at Diagnosis on Prognosis of CML

Armin Leitner, MD, Susanne Saussele, MD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD, PhD, Gudrun Göhring, MD, Susanne Jung-Munkwitz, MD, Ulrike Proetel, MD, Michael Lauseker, Markus Pfirrmann, PhD, Jörg Hasford, MD, Andreas Hochhaus, Rüdiger Hehlmann, MD, The German CML-Study Group

Blood (2010) 116 (21): 355.

https://doi.org/10.1182/blood.V116.21.355.355

Published: 2010

Journal Articles

Hematopathologic Evaluation of Myelodysplastic Features of Patients with CP-CML on Therapy with Clonal Cytogenetic Abnormalities In Ph Negative Clones

Monique A Hartley, MD, Ling Zhang, MD, William Bulkeley, III, MD, Bijal D. Shah, MD, Sara Tinsley, ARNP, Javier Pinilla-Ibarz, MD

Blood (2010) 116 (21): 1224.

https://doi.org/10.1182/blood.V116.21.1224.1224

Published: 2010

Journal Articles

Identification of Novel MHC Class II-Restricted Male-Specific mHAg Encoded by SMCY ( JARID1D ). .

Nobuharu Fujii, MD, PhD, Kellie V Rosinski, Paulo V Campregher, MD, Edus H Warren, III, MD, PhD

Blood (2009) 114 (22): 1344.

https://doi.org/10.1182/blood.V114.22.1344.1344

Published: 2009

Journal Articles

The Role of Microtubule Regulatory Protein Stathmin (STMN1) in Megakaryopoiesis.

Camelia Iancu-Rubin, PhD, Joseph Tripodi, Vesna Najfeld, Ph.D., George F. Atweh, MD

Blood (2009) 114 (22): 4591.

https://doi.org/10.1182/blood.V114.22.4591.4591

Published: 2009

Journal Articles

Front-Line Imatinib Mesylate (IM) in Patients with Newly Diagnosed Accelerated Phase (AP)-Chronic Myeloid Leukemia (CML), a Study From the FILMC Group (France Intergroupe Leucemie Myeloide Chronique).

Delphine Rea, MD, PhD, Gabriel Etienne, MD, Franck Emmanuel Nicolini, MD, PhD, Pascale Cony-Makhoul, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MD, Francoise Huguet, MD, Michel Tulliez, MD, Martine Gardembas, MD, Krimo Bouabdallah, MD, Philippe Rousselot, MD, PhD, Jean-Michel Cayuela, PhD, Herve Dombret, MD, PhD, François-Xavier Mahon, MD, PhD

Blood (2009) 114 (22): 3288.

https://doi.org/10.1182/blood.V114.22.3288.3288

Published: 2009

Journal Articles

A Retrospective Evaluation of Clonal Cytogenetic Abnormalities in Ph Negative Clones in Patients with CP-CML on Therapy

Monique A Hartley, MD, Bijal D. Shah, MD, Sady Armada, Sara Tinsley, Javier Pinilla, MD, PhD

Blood (2008) 112 (11): 4277.

https://doi.org/10.1182/blood.V112.11.4277.4277

Published: 2008

NARROW

Association of Clinical Epidemiologic Exposures and Overall Survival with Genome-Wide DNA Methylation Profiles in Acute Myeloid Leukemia: Analysis of the Mayo Clinic AML Epidemiology Cohort

Utilizing Y Chromosome FISH to Determine the Origin of Post-Transplant Lymphoproliferative Disease in Solid Organ Transplant Recipients

Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?

Indirect Presentation of Y-Chromosome Antigen Dby Is Regulated By Hsc70 and Mediated through CD63 Positive Exosomes

Isolate Loss of Y Chromosome Decreases the Risk of Leukemic Transformation in the Myelodysplastic Syndromes. a Study By the Spanish Group of Myelodysplastic Syndromes

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

The Targeted Disruption of Kdm6a/Utx in Mice Has Gender-Dependent Effects on Primitive Hematopoietic Cell Populations and Myeloid Progenitors

Cytogenetic Features and Prognosis of 943 South American Patients with De Novo Myelodysplastic Syndromes: A Multicenter Study

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Vaccinating Female Donors with Y Chromosome-Encoded Disparities in the Pre-Clinical Canine Model of Allogeneic Hematopoietic Cell Transplantation

Proof of Y-Loss As Clonal Abnormality in MDS by Comparative Analysis of CD34+ and CD3+ Peripheral Blood Cells,

Impact of Additional Cytogenetic Alterations At Diagnosis on Prognosis of CML: Long-Term Observation From 1151 Patients of the Randomized CML Study IV

Loss of the Y Chromosome in MDS - Age-Related Phenomenon or Clonal Abnormality?

In Vitro Expanded MSCs From Patients with Myeloprliferative Neoplasms at Late Passages Show Recurrent Cytogenetic Abnormalities

Impact of Variant t(9;22) and Additional Cytogenetic Aberrations at Diagnosis on Prognosis of CML

Hematopathologic Evaluation of Myelodysplastic Features of Patients with CP-CML on Therapy with Clonal Cytogenetic Abnormalities In Ph Negative Clones

Identification of Novel MHC Class II-Restricted Male-Specific mHAg Encoded by SMCY ( JARID1D ). .

The Role of Microtubule Regulatory Protein Stathmin (STMN1) in Megakaryopoiesis.

Front-Line Imatinib Mesylate (IM) in Patients with Newly Diagnosed Accelerated Phase (AP)-Chronic Myeloid Leukemia (CML), a Study From the FILMC Group (France Intergroupe Leucemie Myeloide Chronique).

A Retrospective Evaluation of Clonal Cytogenetic Abnormalities in Ph Negative Clones in Patients with CP-CML on Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only